Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory bioequivalence study of Levothyroxine Sodium formulations versus Euthyrox in healthy Thai volunteers under fasting
TCTR20260601019Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on TCTR20260601019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260601019.